Stanford University


Showing 141-144 of 144 Results

  • Eitan Yaffe

    Eitan Yaffe

    Affiliate, Medicine - Med/Infectious Diseases

    BioDr. Eitan Yaffe is a computational biologist studying the evolution of natural microbial communities under selective pressures, such as antibiotics. He is currently a research associate in the lab of Dr. David Relman at Stanford University, where he develops experimental and computational approaches to investigate strain dynamics, horizontal gene transfer, and the emergence of antimicrobial resistance in the human microbiome.

    Dr. Yaffe holds a PhD in Computer Science from the Weizmann Institute of Science, where he focused on epigenetics and chromatin folding. He earned his MSc in Computer Science with a specialization in the 3D structure of protein channels, and his BSc in Mathematics and Computer Science from the Hebrew University of Jerusalem.

  • Alex Nathaniel Zimmet

    Alex Nathaniel Zimmet

    Clinical Assistant Professor, Medicine - Infectious Diseases

    BioDr. Zimmet is a board-certified Infectious Disease specialist with a focus on caring for immunocompromised patients, including those who have undergone solid organ or bone marrow transplantation. He is interested in antimicrobial stewardship, especially in immunocompromised patients, as well as education and mentorship of trainees.

  • Andrew Zolopa

    Andrew Zolopa

    Professor of Medicine (Infectious Diseases) at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly InterestsDr. Zolopa’s research applies a variety of clinical epidemiologic methods in an effort to optimize antiretroviral therapy and understand the impact of drug resistance on response to ARV. Areas of focus include the clinical application of resistance testing in optimizing antiretroviral therapy, clinical cohorts, trials of antiretroviral therapies and population-based epidemiologic evaluation of HIV resistance and efficacy of ARV therapy. More recently studies focused on premature aging in HIV.